Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284697688> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4284697688 endingPage "109015" @default.
- W4284697688 startingPage "109015" @default.
- W4284697688 abstract "Immune checkpoint inhibitors (ICIs) are used for a variety of cancers and are associated with a risk of developing immune-related adverse events, most commonly colitis, dermatitis, hepatitis, and thyroiditis. Rare autoimmune hematologic toxicities have been reported but are less well-described in the literature. Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening autoimmune condition that has been reported with ICIs but has been limited to case reports. We performed a retrospective observational analysis of the United States Food and Drug Administration Adverse Event Reporting System (FAERS) data. We searched for cases of TTP reported with exposure to ICIs from initial FDA approval for each agent to December 31, 2021. Disproportionality signal analysis was done by calculating the reporting odds ratio (ROR). There were 35 reports of TTP with ICIs in the FAERS database, including atezolizumab (n = 7), durvalumab (n = 2), nivolumab (n = 18), and pembrolizumab (n = 8). The ROR was significant for atezolizumab (ROR 6.22, 95% CI 2.96–13.09), nivolumab (ROR 3.16, 95% CI 1.99–5.03), and pembrolizumab (ROR 2.56, 95% CI 1.28–5.12). There is a significant reporting signal of TTP with several ICI agents. Clinicians should be aware of and monitor for signs of this potentially serious adverse event." @default.
- W4284697688 created "2022-07-08" @default.
- W4284697688 creator A5017645198 @default.
- W4284697688 creator A5030413349 @default.
- W4284697688 creator A5041957821 @default.
- W4284697688 creator A5051577163 @default.
- W4284697688 creator A5053823821 @default.
- W4284697688 date "2022-09-01" @default.
- W4284697688 modified "2023-10-10" @default.
- W4284697688 title "Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: A real-world study of the FDA adverse event reporting system" @default.
- W4284697688 cites W1893566975 @default.
- W4284697688 cites W1996533737 @default.
- W4284697688 cites W2005018574 @default.
- W4284697688 cites W2564272590 @default.
- W4284697688 cites W2586675028 @default.
- W4284697688 cites W2891486030 @default.
- W4284697688 cites W2917423789 @default.
- W4284697688 cites W2984521008 @default.
- W4284697688 cites W3003958677 @default.
- W4284697688 cites W3042682193 @default.
- W4284697688 cites W3089353561 @default.
- W4284697688 cites W3095103520 @default.
- W4284697688 cites W3153228158 @default.
- W4284697688 cites W4205479823 @default.
- W4284697688 cites W4224280159 @default.
- W4284697688 cites W4226360696 @default.
- W4284697688 doi "https://doi.org/10.1016/j.intimp.2022.109015" @default.
- W4284697688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35803131" @default.
- W4284697688 hasPublicationYear "2022" @default.
- W4284697688 type Work @default.
- W4284697688 citedByCount "3" @default.
- W4284697688 countsByYear W42846976882022 @default.
- W4284697688 countsByYear W42846976882023 @default.
- W4284697688 crossrefType "journal-article" @default.
- W4284697688 hasAuthorship W4284697688A5017645198 @default.
- W4284697688 hasAuthorship W4284697688A5030413349 @default.
- W4284697688 hasAuthorship W4284697688A5041957821 @default.
- W4284697688 hasAuthorship W4284697688A5051577163 @default.
- W4284697688 hasAuthorship W4284697688A5053823821 @default.
- W4284697688 hasConcept C121608353 @default.
- W4284697688 hasConcept C126322002 @default.
- W4284697688 hasConcept C156957248 @default.
- W4284697688 hasConcept C197934379 @default.
- W4284697688 hasConcept C203014093 @default.
- W4284697688 hasConcept C2775949291 @default.
- W4284697688 hasConcept C2777105317 @default.
- W4284697688 hasConcept C2777701055 @default.
- W4284697688 hasConcept C2778585876 @default.
- W4284697688 hasConcept C2779771385 @default.
- W4284697688 hasConcept C2780030458 @default.
- W4284697688 hasConcept C2780057760 @default.
- W4284697688 hasConcept C57658597 @default.
- W4284697688 hasConcept C71924100 @default.
- W4284697688 hasConcept C8891405 @default.
- W4284697688 hasConcept C89560881 @default.
- W4284697688 hasConceptScore W4284697688C121608353 @default.
- W4284697688 hasConceptScore W4284697688C126322002 @default.
- W4284697688 hasConceptScore W4284697688C156957248 @default.
- W4284697688 hasConceptScore W4284697688C197934379 @default.
- W4284697688 hasConceptScore W4284697688C203014093 @default.
- W4284697688 hasConceptScore W4284697688C2775949291 @default.
- W4284697688 hasConceptScore W4284697688C2777105317 @default.
- W4284697688 hasConceptScore W4284697688C2777701055 @default.
- W4284697688 hasConceptScore W4284697688C2778585876 @default.
- W4284697688 hasConceptScore W4284697688C2779771385 @default.
- W4284697688 hasConceptScore W4284697688C2780030458 @default.
- W4284697688 hasConceptScore W4284697688C2780057760 @default.
- W4284697688 hasConceptScore W4284697688C57658597 @default.
- W4284697688 hasConceptScore W4284697688C71924100 @default.
- W4284697688 hasConceptScore W4284697688C8891405 @default.
- W4284697688 hasConceptScore W4284697688C89560881 @default.
- W4284697688 hasLocation W42846976881 @default.
- W4284697688 hasLocation W42846976882 @default.
- W4284697688 hasOpenAccess W4284697688 @default.
- W4284697688 hasPrimaryLocation W42846976881 @default.
- W4284697688 hasRelatedWork W2186633408 @default.
- W4284697688 hasRelatedWork W2706973099 @default.
- W4284697688 hasRelatedWork W2890508535 @default.
- W4284697688 hasRelatedWork W2897473058 @default.
- W4284697688 hasRelatedWork W2939597317 @default.
- W4284697688 hasRelatedWork W2955392295 @default.
- W4284697688 hasRelatedWork W3024972238 @default.
- W4284697688 hasRelatedWork W4242345934 @default.
- W4284697688 hasRelatedWork W4248636606 @default.
- W4284697688 hasRelatedWork W4386307161 @default.
- W4284697688 hasVolume "110" @default.
- W4284697688 isParatext "false" @default.
- W4284697688 isRetracted "false" @default.
- W4284697688 workType "article" @default.